+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Pharmaceutical Excipient Market by Type (Inorganic, Organic), Formulation (Oral Formulations, Parenteral Formulations, Topical Formulations), Function - Forecast 2024-2030- Product Image
Global Pharmaceutical Excipient Market by Type (Inorganic, Organic), Formulation (Oral Formulations, Parenteral Formulations, Topical Formulations), Function - Forecast 2024-2030- Product Image
Sale

Global Pharmaceutical Excipient Market by Type (Inorganic, Organic), Formulation (Oral Formulations, Parenteral Formulations, Topical Formulations), Function - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968715
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pharmaceutical Excipient Market size was estimated at USD 8.62 billion in 2023, USD 9.22 billion in 2024, and is expected to grow at a CAGR of 7.62% to reach USD 14.42 billion by 2030.

Pharmaceutical excipients are added to pharmaceutical products for various purposes, including improving the manufacturing process, enhancing stability, ensuring the bioavailability of the drug, and facilitating the administration and dosing of the final product. Excipients are essentially inactive components that support the overall formulation and delivery of the active ingredient. The market for pharmaceutical excipients is primarily driven by the increasing demand for pharmaceutical products due to the rising global population and chronic diseases. Technological advancements in drug formulation and developing novel excipients also contribute to market growth.

Furthermore, the expansion of the generic pharmaceuticals sector and the trend toward self-medication for minor health issues provide a strong impetus for the excipient market. However, stringent regulatory requirements leading to lengthy approval processes can impede the introduction of new excipients, and the high cost associated with developing and producing advanced excipients hamper its market growth. The shift toward multifunctional and co-processed excipients and ongoing advancements and research activities for developing biobased excipients opens significant opportunities for market players, offering benefits such as improved product performance and production efficiency.

Regional Insights

The Americas region has a significant landscape in the pharmaceutical excipient market as countries exhibit a high demand for excipients, directed by stringent regulatory environments, advanced healthcare systems, and strong intellectual property frameworks. Having a significant landscape in pharmaceutical innovation, the countries in the region strongly focus on advanced and novel excipients for drug formulations. The EMEA region, which encompasses Europe, the Middle East, and Africa, shows diverse market characteristics.

The stringent regulatory environment in the European Union drives the demand for compliant and high-quality excipients, whereas markets in the Middle East and Africa are burgeoning, with increasing investment in pharmaceutical manufacturing infrastructure and regulation. The EU market demonstrates a high need for cutting-edge pharmaceutical excipients that cater to complex drugs and sophisticated drug delivery systems. Moreover, the EU's investment in biopharmaceuticals and biosimilars is complemented by the growing demand for novel excipients in these areas. Countries in the Asia-Pacific region are key players in the pharmaceutical excipient sector experiencing substantial growth due to a large patient pool, increasing healthcare expenditures, and supportive government initiatives. The region focuses on innovating high-functional excipients with ongoing research and development, reducing its historical reliance on imports.

Market Trends by Segment

  • Type: Potential demand and utilization of organic excipients
  • Formulation: Significant demand for oral formulations owing to its convenient drug delivery
  • Function: Coating agents provide physical and chemical protection for the drug

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Roquette Introduces New Advancement in Moisture Protection

Roquette Pharma launched innovative excipient solutions specifically designed to enhance moisture protection. These advanced formulations cater to the growing need for high-performance excipients capable of extending the shelf-life and stability of moisture-sensitive drugs, responding to a critical challenge within the sector. By leveraging cutting-edge technology, Roquette Pharma is poised to set a new standard in excipient functionality, further solidifying its position in the pharmaceutical excipient market.

Clariant Launches New Range Of Excipients To Improve Stability And Solubility of Apis at CPHI Barcelona

Clariant announced the introduction of an innovative portfolio of pharmaceutical experiments, unveiled at CPHI Barcelona. These cutting-edge products are formulated to enhance the stability and solubility of active pharmaceutical ingredients (APIs). The new range addresses critical formulation challenges faced by pharmaceutical companies, enabling easier administration and improved patient compliance.

BASF, IFF Partner on Virtual Pharma Assistant Platform ZoomLab

BASF and International Flavors & Fragrances (IFF) have partnered to create an innovative virtual pharma assistant platform designed to enhance the functionality and application of pharmaceutical excipients. This digital tool aims to streamline the formulation process by providing real-time, data-driven insights and guidance on selecting and combining excipients.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Excipient Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Aceto Corp., Archer Daniels Midland Company, ARMOR PROTEINES S.A.S., Asahi Kasei Corporation, Ashland Inc., BASF SE, BIOGRUND GmbH, Chemische Fabrik Budenheim KG, Clariant AG, Colorcon Inc., Corel Pharma Chem Private Limited, Croda International Plc, Darling Ingredients, Inc., DFE Pharma GmbH & Co KG, DuPont de Nemours, Inc., Evonik Industries AG, Fuji Chemical Industries Co., Ltd., GATTEFOSSE SAS, Innophos Holdings, Inc., International Flavors & Fragrances Inc., JRS PHARMA GmbH + Co. KG, Kerry Group P.L.C., Lipoid GmbH, Lubrizol Corporation, L’AIR LIQUIDE S.A., Mallinckrodt plc, MEGGLE GmbH & Co. KG, Merck KGaA, Nagase & Co., Ltd., Nipon Soda Co., Ltd., NOF Corporation, Omya International AG, Peter Greven GmbH & Co. KG, R.T. Vanderbilt Holding Company, Inc., Resonac Holdings Corporation, Roquette Frères S.A., Shin-Etsu Chemical Co., Ltd., Solvay S.A., SPI Pharma, Inc., and Thermo Fisher Scientific Inc.

This research report offers invaluable insights into various crucial aspects of the Pharmaceutical Excipient Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of cancer and other chronic and infectious diseases worldwide
5.1.1.2. Growth of the pharmaceuticals industry coupled with significant demand for generics & orphan drugs
5.1.1.3. Significant emphasis on the production of multifunctional excipients
5.1.2. Restraints
5.1.2.1. High cost associated with the production of advanced excipient
5.1.3. Opportunities
5.1.3.1. Technological advancements in nanotechnology for excipients
5.1.3.2. Ongoing research and development of excipients with numerous properties (Biobased)
5.1.4. Challenges
5.1.4.1. Increasing regulatory stringency and issues regarding the compatibility of excipients
5.2. Market Segmentation Analysis
5.2.1. Type: Potential demand and utilization of organic excipients
5.2.2. Formulation: Significant demand for oral formulations owing to its convenient drug delivery
5.2.3. Function: Coating agents provide physical and chemical protection for the drug
5.3. Market Trend Analysis
5.3.1. Substantial investments to increase drug manufacturing to propel the demand for pharmaceutical excipient in the Americas
5.3.2. Supportive government initiatives to encourage exports of pharmaceutical products in the Asia-Pacific
5.3.3. Flourishing pharmaceutical sector, coupled with a growing focus on localizing drug manufacturing in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Pharmaceutical Excipient Market, by Type
6.1. Introduction
6.2. Inorganic
6.3. Organic
7. Pharmaceutical Excipient Market, by Formulation
7.1. Introduction
7.2. Oral Formulations
7.3. Parenteral Formulations
7.4. Topical Formulations
8. Pharmaceutical Excipient Market, by Function
8.1. Introduction
8.2. Binders
8.3. Coating Agents
8.4. Colorants
8.5. Disintegrants
8.6. Emulsifying Agents
8.7. Fillers & Diluents
8.8. Flavoring Agents & Sweeteners
8.9. Lubricants & Glidants
8.10. Preservatives
8.11. Suspending & Viscosity Agents
9. Americas Pharmaceutical Excipient Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Pharmaceutical Excipient Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Pharmaceutical Excipient Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Roquette Introduces New Advancement in Moisture Protection
12.3.2. Clariant Launches New Range Of Excipients To Improve Stability And Solubility of Apis at CPHI Barcelona
12.3.3. BASF, IFF Partner on Virtual Pharma Assistant Platform ZoomLab
12.3.4. Lubrizol Licenses Award-Winning Apisolex Excipient to Welton Pharma to Develop a Novel Cancer Therapeutic
12.3.5. Ingredion Announces Strategic Investments Expanding Into High-Value Pharmaceutical Ingredients
12.3.6. DFE Pharma Expands its Inhalation Portfolio with the Launch of Lactohale 400
12.3.7. Evonik invests USD 220 million in partnership with the U.S. Government to build a new lipid production facility for mRNA-based therapies in the U.S.
12.3.8. Lubrizol Launches Apisolex Technology
12.3.9. Univar Solutions Expands Pharmaceutical Products Portfolio Through New Distribution Agreement with Ashland
12.3.10. Azelis Strengthens Its Pharmaceutical Presence in India By Expanding its Partnership With Roquette
12.3.11. Roquette Expands Global Reach of Plant-Based Excipients Portfolio with Complete Acquisition of Crest Cellulose
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. PHARMACEUTICAL EXCIPIENT MARKET RESEARCH PROCESS
FIGURE 2. PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PHARMACEUTICAL EXCIPIENT MARKET DYNAMICS
FIGURE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PHARMACEUTICAL EXCIPIENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. PHARMACEUTICAL EXCIPIENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PHARMACEUTICAL EXCIPIENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, BY REGION, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, BY REGION, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, BY REGION, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, BY REGION, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, BY REGION, 2024-2030 (USD MILLION)
TABLE 75. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 76. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 77. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 78. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 79. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 80. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 81. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 82. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 83. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 84. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 85. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 86. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 87. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 88. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 89. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 90. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 91. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 92. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 93. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 94. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 95. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 96. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 97. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2023 (USD MILLION)
TABLE 98. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, BY REGION, 2024-2030 (USD MILLION)
TABLE 99. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 100. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 101. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 102. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 103. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
TABLE 104. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
TABLE 105. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
TABLE 106. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
TABLE 107. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
TABLE 108. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
TABLE 109. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
TABLE 110. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
TABLE 111. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
TABLE 112. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
TABLE 113. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 114. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 115. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 116. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 117. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 118. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 119. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 120. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 121. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
TABLE 124. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
TABLE 125. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
TABLE 126. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
TABLE 127. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
TABLE 128. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
TABLE 129. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
TABLE 130. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
TABLE 131. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
TABLE 132. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
TABLE 133. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 134. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 135. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 136. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 137. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 138. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 139. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 140. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 141. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
TABLE 142. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
TABLE 143. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
TABLE 144. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
TABLE 145. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
TABLE 146. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
TABLE 147. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
TABLE 148. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
TABLE 149. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
TABLE 150. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
TABLE 151. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 152. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 153. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 154. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 155. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 156. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 157. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
TABLE 160. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
TABLE 161. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
TABLE 162. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
TABLE 163. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
TABLE 164. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
TABLE 165. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
TABLE 166. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
TABLE 167. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
TABLE 168. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
TABLE 169. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 170. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 171. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 172. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 173. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 174. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 175. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 176. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 177. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
TABLE 178. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
TABLE 179. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
TABLE 180. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
TABLE 181. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
TABLE 182. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
TABLE 183. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
TABLE 184. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
TABLE 185. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
TABLE 186. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
TABLE 187. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 188. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 189. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 190. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 191. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 192. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 193. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 194. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 195. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
TABLE 196. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
TABLE 197. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
TABLE 198. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
TABLE 199. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
TABLE 200. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
TABLE 201. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
TABLE 202. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
TABLE 203. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
TABLE 204. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
TABLE 205. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 206. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 207. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 208. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 209. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 210. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 211. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 212. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 214. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
TABLE 216. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
TABLE 218. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
TABLE 220. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
TABLE 222. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
TABLE 224. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 226. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 228. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 230. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 232. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 233. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 234. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 235. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
TABLE 236. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
TABLE 237. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
TABLE 238. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
TABLE 239. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
TABLE 240. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
TABLE 241. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
TABLE 242. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
TABLE 243. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
TABLE 244. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
TABLE 245. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 246. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 247. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 248. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 249. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 250. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 251. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 252. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 253. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
TABLE 254. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
TABLE 255. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
TABLE 256. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
TABLE 257. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
TABLE 258. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
TABLE 259. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
TABLE 260. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
TABLE 261. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
TABLE 262. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
TABLE 263. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 264. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 265. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 266. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 267. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 268. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 269. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 270. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 271. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
TABLE 272. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
TABLE 273. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
TABLE 274. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
TABLE 275. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
TABLE 276. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
TABLE 277. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
TABLE 278. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
TABLE 279. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
TABLE 280. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
TABLE 281. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 282. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 283. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 284. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 285. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 286. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 287. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 288. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 289. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
TABLE 290. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
TABLE 291. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
TABLE 292. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
TABLE 293. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
TABLE 294. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
TABLE 295. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
TABLE 296. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
TABLE 297. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
TABLE 298. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
TABLE 299. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 300. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 301. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 302. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 303. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 304. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 305. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 306. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 307. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
TABLE 308. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
TABLE 309. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
TABLE 310. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
TABLE 311. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
TABLE 312. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
TABLE 313. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2023 (USD MILLION)
TABLE 314. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2024-2030 (USD MILLION)
TABLE 315. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2023 (USD MILLION)
TABLE 316. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2024-2030 (USD MILLION)
TABLE 317. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 318. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 319. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2023 (USD MILLION)
TABLE 320. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2024-2030 (USD MILLION)
TABLE 321. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 322. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 323. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 324. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 325. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2023 (USD MILLION)
TABLE 326. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2024-2030 (USD MILLION)
TABLE 327. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2023 (USD MILLION)
TABLE 328. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2024-2030 (USD MILLION)
TABLE 329. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
TABLE 330. MALAYSIA P

Companies Mentioned

  • ABITEC Corporation
  • Aceto Corp.
  • Archer Daniels Midland Company
  • ARMOR PROTEINES S.A.S.
  • Asahi Kasei Corporation
  • Ashland Inc.
  • BASF SE
  • BIOGRUND GmbH
  • Chemische Fabrik Budenheim KG
  • Clariant AG
  • Colorcon Inc.
  • Corel Pharma Chem Private Limited
  • Croda International Plc
  • Darling Ingredients, Inc.
  • DFE Pharma GmbH & Co KG
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • Fuji Chemical Industries Co., Ltd.
  • GATTEFOSSE SAS
  • Innophos Holdings, Inc.
  • International Flavors & Fragrances Inc.
  • JRS PHARMA GmbH + Co. KG
  • Kerry Group P.L.C.
  • Lipoid GmbH
  • Lubrizol Corporation
  • L’AIR LIQUIDE S.A.
  • Mallinckrodt plc
  • MEGGLE GmbH & Co. KG
  • Merck KGaA
  • Nagase & Co., Ltd.
  • Nipon Soda Co., Ltd.
  • NOF Corporation
  • Omya International AG
  • Peter Greven GmbH & Co. KG
  • R.T. Vanderbilt Holding Company, Inc.
  • Resonac Holdings Corporation
  • Roquette Frères S.A.
  • Shin-Etsu Chemical Co., Ltd.
  • Solvay S.A.
  • SPI Pharma, Inc.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 9.22 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.42 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned41

Related Topics

Related Reports

Global Organic Pharmaceutical Excipients Market by Function (Binders, Coating Agents, Colorants), Form (Oral Formulations, Parenteral Formulations, Topical Formulations), Product - Forecast 2024-2030 - Product Image

Global Organic Pharmaceutical Excipients Market by Function (Binders, Coating Agents, Colorants), Form (Oral Formulations, Parenteral Formulations, Topical Formulations), Product - Forecast 2024-2030

  • Report
  • 190 Pages
  • Global
From
Pharmaceutical Excipients Market by Product (Organic (Oleochemicals, Carbohydrates) Inorganic (Calcium Carbonate), Functionality (Fillers, Binders, Lubricants, Diluents), Formulation (Oral, Parenteral), Application (Stablizers) - Global Forecast to 2028 - Product Image

Pharmaceutical Excipients Market by Product (Organic (Oleochemicals, Carbohydrates) Inorganic (Calcium Carbonate), Functionality (Fillers, Binders, Lubricants, Diluents), Formulation (Oral, Parenteral), Application (Stablizers) - Global Forecast to 2028

  • Report
  • 504 Pages
  • Global
From
Organic Pharmaceutical Excipients Global Market Report 2024 - Product Image

Organic Pharmaceutical Excipients Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Biopharmaceutical Excipients Market by Product (Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers), Function (Binders, Coatings, Disintegrants), Application - Forecast 2024-2030 - Product Image

Global Biopharmaceutical Excipients Market by Product (Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers), Function (Binders, Coatings, Disintegrants), Application - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
Global Nutraceutical Excipients Market by Product Source (Organic Chemicals, Inorganic Chemicals), Functionality (Binders, Colorants, Flavors & Sweeteners), End Product, Formulation, Functionality Application and Region - Forecast to 2028 - Product Image

Global Nutraceutical Excipients Market by Product Source (Organic Chemicals, Inorganic Chemicals), Functionality (Binders, Colorants, Flavors & Sweeteners), End Product, Formulation, Functionality Application and Region - Forecast to 2028

  • Report
  • 379 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.